Not recruiting
Meningococcal infection
Not recruitingRegistered drugNo placebo
Study of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years
Registered drugNo placebo
- Disease:Meningococcal infection
- Substances:Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium HydroxideRecombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide+2
Countries:
Finland
Finland- Participants:0–17 years · 18–64 years · Healthy volunteers
- Substances:Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
- Sponsor:GlaxoSmithKline Biologicals
